Protocol for a feasibility registry-based randomised controlled trial investigating a tailored follow-up service for stroke (A-LISTS)

Simple item page
dc.contributor.authorCadilhac, D.A.
dc.contributor.authorRoss, A.G.
dc.contributor.authorBagot, K.L.
dc.contributor.authorBlennerhassett, J.M.
dc.contributor.authorKilkenny, M.F.
dc.contributor.authorKim, J.
dc.contributor.authorPurvis, T.
dc.contributor.authorBarclay, K.M.
dc.contributor.authorEllery, F.
dc.contributor.authorMorrison, J.
dc.contributor.authorCranefield, J.
dc.contributor.authorKleinig, T.J.
dc.contributor.authorGrimley, R.
dc.contributor.authorJaques, K.
dc.contributor.authorWong, D.
dc.contributor.authorMurphy, L.
dc.contributor.authorRussell, G.
dc.contributor.authorNelson, M.R.
dc.contributor.authorThijs, V.
dc.contributor.authorScott, C.
dc.contributor.authoret al.
dc.date.issued2024
dc.description.abstractBackground Stroke affects long-term physical and cognitive function; many survivors report unmet health needs, such as pain or depression. A hospital-led follow-up service designed to address ongoing health problems may avoid unplanned readmissions and improve quality of life. Methods This paper outlines the protocol for a registry-based, randomised controlled trial with allocation concealment of participants and outcome assessors. Based on an intention-to-treat analysis, we will evaluate the feasibility, acceptability, potential effectiveness and cost implications of a new tailored, codesigned, hospital-led follow-up service for people within 6–12 months of stroke. Participants (n=100) from the Australian Stroke Clinical Registry who report extreme health problems on the EuroQol EQ-5D-3L survey between 90 and 180 days after stroke will be randomly assigned (1:1) to intervention (follow-up service) or control (usual care) groups. All participants will be independently assessed at baseline and 12–14-week post-randomisation. Primary outcomes for feasibility are the proportion of participants completing the trial and for intervention participants the proportion that received follow-up services. Acceptability is satisfaction of clinicians and participants involved in the intervention. Secondary outcomes include effectiveness: change in extreme health problems (EQ-5D-3L), unmet needs (Longer-term Unmet Needs questionnaire), unplanned presentations and hospital readmission, functional independence (modified Rankin Scale) and cost implications estimated from self-reported health service utilisation and productivity (e.g. workforce participation). To inform future research or implementation, the design contains a process evaluation including clinical protocol fidelity and an economic evaluation. Discussion The results of this study will provide improved knowledge of service design and implementation barriers and facilitators and associated costs and resource implications to inform a future fully powered effectiveness trial of the intervention.
dc.description.statementofresponsibilityDominique A. Cadilhac, Andrew G. Ross, Kathleen L. Bagot, Jannette M. Blennerhassett, Monique F. Kilkenny, Joosup Kim, Tara Purvis, Karen M. Barclay, Fiona Ellery, Julie Morrison, Jennifer Cranefeld, Timothy J. Kleinig, Rohan Grimley, Katherine Jaques, Dana Wong, Lisa Murphy, Grant Russell, Mark R. Nelson, Vincent Thijs, Colin Scott, and Sandy Middleton, on behalf of the A-LISTS investigator group
dc.identifier.citationPilot and Feasibility Studies, 2024; 10(1):103-1-103-12
dc.identifier.doi10.1186/s40814-024-01527-y
dc.identifier.issn2055-5784
dc.identifier.issn2055-5784
dc.identifier.orcidKleinig, T.J. [0000-0003-4430-3276]
dc.identifier.urihttps://hdl.handle.net/2440/144066
dc.language.isoen
dc.publisherBMC
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1154273
dc.rights© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
dc.source.urihttp://dx.doi.org/10.1186/s40814-024-01527-y
dc.subjectStroke; Clinical trial protocol; Follow-up service; Clinical Quality Registry
dc.titleProtocol for a feasibility registry-based randomised controlled trial investigating a tailored follow-up service for stroke (A-LISTS)
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_144066.pdf
Size:
1.62 MB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

Research Outputs